Skip to content

Turning Point Therapeutics, Inc.

CIK 0001595893

← back to feed
Revenue (TTM)
$6.17M
+23.3% YoY Q2 Aug 2022
Net Income (TTM)
−$320.13M
−399.3% YoY Q2 Aug 2022
EPS Diluted (TTM)
—
Q2 Aug 2022
Gross Margin
—
Q2 Aug 2022
Operating Margin
-5,227.0%
Q2 Aug 2022
Net Margin
-5,186.8%
Q2 Aug 2022
Free Cash Flow (TTM)
−$113.11M
Q2 Aug 2022
Cash
$290.15M
Q2 Aug 2022
Total Debt
—
Q2 Aug 2022
Shares Outstanding
50.07M sh
Q2 Aug 2022

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings